Danimer Scientific, Inc.
DNMR · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,175 | $2,620 | $4,367 | $4,168 |
| - Cash | $22 | $40 | $57 | $59 |
| + Debt | $413 | $419 | $410 | $408 |
| Enterprise Value | $2,566 | $2,999 | $4,720 | $4,516 |
| Revenue | $9 | $8 | $10 | $11 |
| % Growth | 13.1% | -25.4% | -6.6% | – |
| Gross Profit | -$7 | -$7 | -$9 | -$9 |
| % Margin | -84.8% | -90.5% | -85% | -78.5% |
| EBITDA | -$19 | -$6 | -$11 | -$23 |
| % Margin | -218.1% | -80.6% | -107.5% | -214.3% |
| Net Income | -$22 | -$23 | -$27 | -$39 |
| % Margin | -253.1% | -297.1% | -266.7% | -360.3% |
| EPS Diluted | -7.2 | -0.19 | -0.26 | -0.39 |
| % Growth | -3,689.5% | 26.9% | 33.3% | – |
| Operating Cash Flow | -$14 | -$19 | -$13 | $17 |
| Capital Expenditures | -$4 | -$2 | -$2 | -$2 |
| Free Cash Flow | -$18 | -$21 | -$15 | $15 |